FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Efficacy and Safety of IRR Combo in Untreated FL and MZL May 30, 2024
FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Evaluating Imaging for Indolent Cutaneous B-cell Lymphomas May 24, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma HBsAg Positive Linked to Worse DLBCL Prognosis May 15, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Managing CAR-T Failure: Chidamide & PD-1 Blockade in LBCL May 14, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Optimizing CAR-T Outcomes: Effective Bridging Strategies May 08, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma eIF3a in DLBC: Prognostic Biomarker +Therapeutic Target Apr 30, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Enhancing CAR-T Therapy With Nivolumab: Final Analysis Apr 25, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Combination Therapy: HDT/ASCT With CNCT19 Apr 25, 2024
